INVO (invobioscience.com) Earnings per share growth this year

Official company branding of INVO Bioscience, Inc. (INVO)

The automation of embryo maturation reduces reliance on manual labor, which impacts profit volatility for INVO Bioscience, Inc. (INVO). The 12-month EPS growth percentage visualizes these fluctuations, where 92.70 represents the current metric level. Risks associated with cyclical demand for expensive IVF are mitigated by expanding sales geography and growing clinic interest in affordable infertility treatment methods.

INVO (INVO Bio) Earnings per share growth in current year history from 07/04/2022 to 04/28/2025

Financial and market metric breakdowns for invobioscience.com (INVO)

- stock value and consensus price forecast:
Market Price INVO Bioscience|INVO - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization INVO Bioscience, Inc.|INVO - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share INVO Bioscience|INVO - Company Book Value|Market Cap to Net Assets Ratio invobioscience.com|INVO - Company Total Assets
- debt and solvency information:
Debt to Capital INVO Bioscience, Inc.|INVO - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio INVO Bioscience|INVO - Company Aggregate Debts|Debts to Net Assets INVO Bioscience, Inc.|INVO - Company Long-Term Debts|Company Current Liabilities INVO Bioscience|Quick Ratio invobioscience.com
- net income and valuation multiples indicators:
INVO - Company Net Income|Expected Profit INVO Bioscience, Inc.|INVO - Price to Earnings Ratio|Future Price to Earnings Multiple INVO Bioscience|INVO - PEG Multiple|Company Value to EBITDA INVO Bioscience, Inc.|INVO - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year INVO Bioscience|INVO - Net earnings per share for the last 12 months|Quarterly EPS earnings growth invobioscience.com|INVO - Earnings growth in current year|Consensus forecast of earnings per share growth for next year INVO Bioscience, Inc.
Fundamental valuation:INVO - INVO Bio
Signature product of INVO Bio

Assessing the financial stability of INVO Bioscience, Inc. (INVO) requires an analysis of real income dynamics. This indicator measures the percentage deviation of current earnings per share from the same period last year, revealing the true efficiency of the business. By analyzing the YoY net income per share growth rate, an investor can determine the extent to which the commercialization of cultivation systems and the expansion of the clinic network translate into actual growth in capitalization.

Direct competitors

Earnings per share growth rate in current year Boston Scientific Corp (BSX)|EW (Edwards Lifesciences Corp) - Earnings growth in current year|Earnings per share growth this year RMD (ResMed Corporation)|Net earnings per share growth this year PODD (Insulet Corporation)|ZBH (Zimmer Biomet Holdings, Inc.) - Earnings per share increase in current year|Earnings per share growth in current year CooperCompanies COO|ALGN - Net earnings per share growth this year|Globus Medical Corp - Earnings growth in current year|Earnings per share growth rate in current year TransMedics Group|ATEC: Earnings growth in current year|Earnings per share growth this year AORT|ENOV (Enovis) - Earnings growth in current year|Integra LifeSciences Corp (IART) - Expected net earnings per share growth this year|Earnings growth in current year ESTA|Net earnings per share growth this year iLet Bionic Pancreas BBNX|Earnings growth in current year IRMD (IRADIMED CORPORATION)|Earnings growth in current year embecta.com EMBC|TNDM - Earnings per share growth in current year|AXGN: Earnings per share growth in current year|SIBN (SI-BONE Corp) - Net earnings per share growth this year|Orthofix Corp - Earnings per share increase in current year|BVS (Bioventus Inc.) - Earnings growth in current year|Earnings per share growth rate in current year OrthoPediatrics Inc. KIDS|Earnings per share growth in current year Treace Medical Concepts, Inc. (TMCI)|Blade Air Mobility (SRTA) - Net earnings per share change in current year|Carlsmed Corp - Net earnings per share growth this year|Earnings growth in current year RxSight Ophthalmic RXST|ClearPoint - Earnings growth in current year|Expected net earnings per share growth this year stereotaxis.com STXS|Neuronetics (STIM) - Earnings per share growth in current year|Earnings per share trend in current year SGHT (Sight Sciences Inc.)|Earnings per share growth in current year Orchestra BioMed, Inc.|Net earnings per share growth this year Anika (ANIK)|Earnings growth in current year NSPR|ZJYL - Earnings per share growth rate in current year|Earnings per share growth in current year Vivani Medical VANI|XTNT: Earnings per share growth this year|NMTC: Net earnings per share growth this year|Modular Medical - Net earnings per one share growth for the current year|MYO: Earnings growth in current year|COCH - Expected net earnings per share growth this year|Earnings per share growth in current year Vivos Therapeutics, Inc.|Earnings per share growth this year NVNO (enVVeno Medical Corporation)|Net earnings per share growth this year SINT (Sintx Technologies)|Earnings per share growth in current year TNON (Tenon Medical Inc)|Earnings per share growth in current year ReWalk Robotics Ltd. LFWD|Autonomix Medical Inc. (AMIX) - Earnings per share growth rate in current year|IVF: Net earnings per share growth this year|Earnings per share increase in current year BBLG (Bone Biologics Corp.)|AXNX: Earnings growth in current year|BIOL (Biolase Inc.) - Earnings per share growth in current year|DYNT (Dynatronics Corp) - Earnings growth in current year|Paragon 28 Corp (FNA) - Expected net earnings per share growth this year